Your session is about to expire
← Back to Search
Peer Coaching for Eating Disorders
N/A
Waitlist Available
Led By Tom Hildebrandt, PsyD
Research Sponsored by Icahn School of Medicine at Mount Sinai
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial will help to develop a coaching approach to aid in the treatment of eating disorders which may help to improve emotional well-being for caregivers and patients while also strengthening skills necessary for recovery.
Who is the study for?
This trial is for English-speaking children aged 12-18 with an eating disorder diagnosis, who are receiving treatment at a specific center and have access to a phone with WiFi or data. Both the parent and child must be willing to participate. It's not suitable for those with learning or developmental disorders, or if there's an acute suicide risk.
What is being tested?
The study is testing a peer-coaching model over twelve weeks as part of standard eating disorder treatment. Participants will be randomly assigned to either receive parent coaching plus patient educational materials, or vice versa, aiming to reduce caregiver stress and enhance patient recovery skills.
What are the potential side effects?
Since this trial involves education and coaching rather than medication, traditional side effects are not expected. However, participants may experience emotional discomfort when discussing sensitive topics related to eating disorders during sessions.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Eating Disorders
Secondary study objectives
Mental Depression
Anxiety
Anorexia
+4 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Parent Education and Patient CoachingExperimental Treatment1 Intervention
This group includes 12 weeks of eating disorder therapy provided to the patient. Outside of therapy, parents will have access to weekly educational material and patients will have access to a coach.
Group II: Parent Coaching and Patient EducationExperimental Treatment1 Intervention
This group includes 12 weeks of eating disorder therapy provided to the patient. Outside of therapy, parents will have access to a coach and patients will have access to weekly educational material.
Find a Location
Who is running the clinical trial?
Icahn School of Medicine at Mount SinaiLead Sponsor
914 Previous Clinical Trials
572,831 Total Patients Enrolled
1 Trials studying Eating Disorders
59 Patients Enrolled for Eating Disorders
Tom Hildebrandt, PsyDPrincipal InvestigatorIcahn School of Medicine at Mount Sinai
5 Previous Clinical Trials
611 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Both my child and I agree to participate.I am 12-18 years old, diagnosed with an eating disorder, enrolled in treatment, speak English, have phone access, and both my parent and I agree to participate.I have been diagnosed with an eating disorder.I am between 12 and 18 years old.
Research Study Groups:
This trial has the following groups:- Group 1: Parent Education and Patient Coaching
- Group 2: Parent Coaching and Patient Education
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.